M Eskelinen
- Oncology top 10%
- Molecular Biology
- Surgery top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- P. LipponenS. AaltomaaKarí SyrjänenVeli‐Matti KosmaTimo PietiläinenErkki PesonenMartti Ala‐OpasP Lipponen
- Topics
- Breast Cancer Treatment Studies (11 papers)Cancer Risks and Factors (6 papers)Glycosylation and Glycoproteins Research (5 papers)
- Cited by
- Cancer ResearchOncologySurgery
In The Last Decade
M Eskelinen
34 papers receiving 935 citations
Peers
Comparison fields: 5 of 98
- Oncology 444
- Molecular Biology 405
- Surgery 289
- Cancer Research 283
- Pulmonary and Respiratory Medicine 188
Countries citing papers authored by M Eskelinen
This map shows the geographic impact of M Eskelinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Eskelinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Eskelinen more than expected).
Fields of papers citing papers by M Eskelinen
This network shows the impact of papers produced by M Eskelinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Eskelinen. The network helps show where M Eskelinen may publish in the future.
Co-authorship network of co-authors of M Eskelinen
This figure shows the co-authorship network connecting the top 25 collaborators of M Eskelinen. A scholar is included among the top collaborators of M Eskelinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Eskelinen. M Eskelinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 22 | |
| 3 | 42 | |
| 4 | 44 | |
| 5 | 62 | |
| 6 | 38 | |
| 7 | 45 | |
| 8 | 20 | |
| 9 | 47 | |
| 10 | 0 | |
| 11 | 138 | |
| 12 | 196 | |
| 13 | The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study. | 1 |
| 14 | 14 | |
| 15 | 21 | |
| 16 | 13 | |
| 17 | Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance. | 11 |
| 18 | 9 | |
| 19 | 5 | |
| 20 | 29 |
About M Eskelinen
M Eskelinen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 36 papers that have together received 969 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Risks and Factors (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Cancer Research (283 citations), Oncology (444 citations) and Surgery (289 citations). M Eskelinen has collaborated with scholars based in Finland, Sweden and Japan. Frequent co-authors include P. Lipponen, S. Aaltomaa, Karí Syrjänen, Veli‐Matti Kosma, Timo Pietiläinen, Erkki Pesonen, Veli‐Matti Kosma, Martti Ala‐Opas, P Lipponen and E. Alhava. Their work appears in journals such as British Journal of Cancer, European Urology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.